Fukuda K - Search Results

1

Anthropometric and other risk factors for ovarian cancer in a case-control study.

Mori M, Nishida T, Sugiyama T, Komai K, Yakushiji M, Fukuda K, Tanaka T, Yokoyama M, Sugimori H. Mori M, et al. Among authors: fukuda k. Jpn J Cancer Res. 1998 Mar;89(3):246-53. doi: 10.1111/j.1349-7006.1998.tb00555.x. Jpn J Cancer Res. 1998. PMID: 9600117 Free PMC article.

2

[A case-control study of ovarian cancer to identify its risk factors].

Mori M, Nishimura H, Nishida T, Sugiyama T, Komai K, Ide H, Yakushiji M, Fukuda K, Tanaka T, Yokoyama M, Sugimori H. Mori M, et al. Among authors: fukuda k. Nihon Sanka Fujinka Gakkai Zasshi. 1996 Oct;48(10):875-82. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8921519 Japanese.

3

Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.

Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H, Yamasaki F. Fukuda K, et al. Gynecol Oncol. 1999 Mar;72(3):273-7. doi: 10.1006/gyno.1998.5244. Gynecol Oncol. 1999. PMID: 10053095

4

[The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].

Tanaka T, Iwasaka T, Hayashi Y, Hachisuga T, Yokoyama M, Ohkuma Y, Matsuo N, Fukuda K, Sugimori H. Tanaka T, et al. Among authors: fukuda k. Nihon Gan Chiryo Gakkai Shi. 1990 Jun 20;25(6):1157-61. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 1975831 Japanese.

5

Growth suppression of a cervical cancer cell line (TMCC-1) by the human wild-type p53 gene.

Zheng PS, Iwasaka T, Ouchida M, Fukuda K, Yokoyama M, Sugimori H. Zheng PS, et al. Among authors: fukuda k. Gynecol Oncol. 1996 Feb;60(2):245-50. doi: 10.1006/gyno.1996.0033. Gynecol Oncol. 1996. PMID: 8631546

6

Telomerase activation in cervical neoplasia.

Iwasaka T, Zheng PS, Yokoyama M, Fukuda K, Nakao Y, Sugimori H. Iwasaka T, et al. Among authors: fukuda k. Obstet Gynecol. 1998 Feb;91(2):260-2. doi: 10.1016/s0029-7844(97)00595-4. Obstet Gynecol. 1998. PMID: 9469286

7

Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.

Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Fukuda K, et al. Gynecol Oncol. 1998 Jun;69(3):220-5. doi: 10.1006/gyno.1998.5023. Gynecol Oncol. 1998. PMID: 9648591

8

Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.

Iwasaka T, Fukuda K, Hara K, Yokoyama M, Nakao Y, Uchiyama M, Sugimori H. Iwasaka T, et al. Among authors: fukuda k. Gynecol Oncol. 1998 Aug;70(2):236-40. doi: 10.1006/gyno.1998.5079. Gynecol Oncol. 1998. PMID: 9740697

9

Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.

Iwai K, Fukuda K, Hachisuga T, Mori M, Uchiyama M, Iwasaka T, Sugimori H. Iwai K, et al. Among authors: fukuda k. Gynecol Oncol. 1999 Mar;72(3):351-9. doi: 10.1006/gyno.1998.5286. Gynecol Oncol. 1999. PMID: 10053107

10

Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement.

Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M, Sugimori H. Hayashi Y, et al. Among authors: fukuda k. Gynecol Oncol. 1991 Feb;40(2):147-51. doi: 10.1016/0090-8258(91)90107-g. Gynecol Oncol. 1991. PMID: 1707025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,308 results

Search Page